Results 141 to 150 of about 3,490 (181)

Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use. [PDF]

Curr Atheroscler Rep
Porterfield LR, Nadeem S, Swanson D, Hayek SS, Vaughan EM.   +4 more
europepmc   +1 more source

Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation. [PDF]

Drug Des Devel Ther
Tobaiqy M, Alqutub ST.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MEN2 in Clinical Practice

Endocrinology, 2021
Antongiulio Faggiano, Elisa Giannetta
exaly   +4 more sources

Primary Hyperparathyroidism in MEN2 Syndromes

Recent Results in Cancer Research, 2015
One of the components of the classical form of MEN2 syndromes is primary hyperparathyroidism (PHP). It occurs in 20-30% of the typical MEN2A syndrome. Recently, the prevalence in ret gene carriers is rarer possibly due to the increased recognition of cases who have familial MTC only. PHP is diagnosed more frequently in association with the exon 11, 634
Maria Alevizaki
exaly   +6 more sources